This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital healthtechnology and develop digital biomarkers for Parkinson’s disease.
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions. We are on Twitter.
My name is Rachel Francine and I am the co-founder and CEO of musical healthtechnologies, we created a digital health platform, Singfit. Carrie: Tell me a little bit about yourself and what brings you to the Connected Health Conference? Digital Health Today would not be possible without our valuable partners.
The top three sectors for investment were: Digital health (£244 million) Therapeutics (£225 million) Medtech (£136 million) Some of the notable deals in 2022 included: Amphista Therapeutics (£38 million) Resolution Therapeutics (£34 million) ODx (£7.6 This talent pool is a major asset for the healthtech sector. (1)
The key trends that are expected to shape the market in 2023 include: Increased focus on digital health: Healthcare companies are increasingly looking to acquire digital health businesses in order to improve their offerings and stay ahead of the competition.
The top three sectors for investment were: Digital health (£244 million) Therapeutics (£225 million) Medtech (£136 million) Some of the notable deals in 2022 included: Amphista Therapeutics (£38 million) Resolution Therapeutics (£34 million) ODx (£7.6 At the top is Glasgow-based Amphista Therapeutics, which raised $50m in 2022.
They've shown steady growth, potentially nearing profitability, and established themselves as a valuable partner for health insurance companies and PBMs. Dialogue Health Technologies:A provider of virtual care services for chronic conditions. They seem to be well-funded to continue development efforts.
They've shown steady growth, potentially nearing profitability, and established themselves as a valuable partner for health insurance companies and PBMs. Dialogue HealthTechnologies: A provider of virtual care services for chronic conditions. They seem to be well-funded to continue development efforts.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content